Literature DB >> 9524853

Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections.

L G Reimer1, K C Carroll.   

Abstract

The appropriate use of the clinical microbiology laboratory for diagnosing lower respiratory tract infections is controversial. As in clinical care, it is crucial to categorize the presenting illness properly as acute bronchitis, an acute exacerbation of chronic bronchitis, community-acquired pneumonia, or nosocomial pneumonia if diagnostic efforts to establish a microbial etiology are to be productive for the individual patient and affordable to society. The greatest potential benefit of microbiological investigations lies in the etiologic diagnosis of pneumonia. For community-acquired pneumonia, evaluation of a gram-stained smear of sputum in terms of both quality and microorganisms present can help guide initial therapy as well as aid interpretation of subsequent culture results. As discussed in this review, the role of the clinical microbiology laboratory in the etiologic diagnosis of nosocomial and complicated pneumonias is more extensive and, in addition to evaluation of respiratory secretions, may include cultures of blood, pleural fluid, and specimens obtained by bronchoscopy. However, a prerequisite for the use of all currently available tests is their deployment for patients with clinical and radiographic evidence of pneumonia.

Entities:  

Mesh:

Year:  1998        PMID: 9524853     DOI: 10.1086/514583

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study.

Authors:  M L Lorente; M Falguera; A Nogués; A R González; M T Merino; M R Caballero
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

2.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

3.  Community-Acquired Pneumonia: An Overview.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

Review 4.  Laboratory diagnosis of lower respiratory tract infections: controversy and conundrums.

Authors:  Karen C Carroll
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart.

Authors:  M Khanna; J Fan; K Pehler-Harrington; C Waters; P Douglass; J Stallock; S Kehl; K J Henrickson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

6.  Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals.

Authors:  D P Kofteridis; J A Papadakis; D Bouros; P Nikolaides; G Kioumis; S Levidiotou; E Maltezos; S Kastanakis; S Kartali; A Gikas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

7.  Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients.

Authors:  Samuel Yang; Shin Lin; Ambreen Khalil; Charlotte Gaydos; Eric Nuemberger; George Juan; Justin Hardick; John G Bartlett; Paul G Auwaerter; Richard E Rothman
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

8.  Clinical evaluation methods for new antimicrobial agents to treat respiratory infections: Report of the Committee for the Respiratory System, Japan Society of Chemotherapy.

Authors:  A. Saito; Fumio Miki; Kotaro Oizumi; Naoto Rikitomi; Akira Watanabe; Hironobu Koga; Yoshito Niki; Nobuchika Kusano
Journal:  J Infect Chemother       Date:  1999-06       Impact factor: 2.211

9.  Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens.

Authors:  Maja Kodani; Genyan Yang; Laura M Conklin; Tatiana C Travis; Cynthia G Whitney; Larry J Anderson; Stephanie J Schrag; Thomas H Taylor; Bernard W Beall; Robert F Breiman; Daniel R Feikin; M Kariuki Njenga; Leonard W Mayer; M Steven Oberste; Maria Lucia C Tondella; Jonas M Winchell; Stephen L Lindstrom; Dean D Erdman; Barry S Fields
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

10.  [Community-acquired and nosocomial pneumonia].

Authors:  T Welte
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.